Neuphoria Therapeutics: extends rights plan to Oct 27, 2027

What happened

• The board of Neuphoria Therapeutics Inc. entered into Amendment No. 1 (the “Amendment”) to the Rights Agreement dated Oct 27, 2025 between the company and Computershare Trust Company, N.A., as rights agent.
• The Amendment, entered into on Oct 23, 2026, extends the Final Expiration Date of the Original Rights Agreement until the close of business on Oct 27, 2027, unless earlier extended, modified or terminated.

Key details

• Amendment No. 1 dated Oct 23, 2026.
• Original Rights Agreement dated Oct 27, 2025 with Computershare Trust Company, N.A. as rights agent.
• Final Expiration Date extended to the close of business on Oct 27, 2027.
• The Rights remain governed by the Original Rights Agreement except as amended; the Amendment is attached as Exhibit 4.2 and the Original Rights Agreement is incorporated by reference to prior filings.

Why it may matter

• The filing reports Item 1.01 (entry into a material definitive agreement) and Item 3.03 (material modification to rights of security holders), which cover the Amendment to the rights agreement and the extension of its final expiration date.
• The filing does not show why the insider traded or why the company acted.